Groowe
/
Newsroom
/ KRYS
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KRYS
News
Krystal Biotech, Inc. Common Stock
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis
globenewswire.com
Oct 14, 2025 2:00 AM
KRYS
← Newer
Page 3 of 3
Older →